Waseda spinout developing ultra-sensitive protein biomarker detection (TN-cyclon) for cancer/neuro diseases
| Date | Round | Amount |
|---|---|---|
| Nov 2024 | Seed BioPhenoMA, a Waseda University spinout developing ultra-sensitive protein-biomarker assays, raised about 190M JPY in a pre-Series A from Waseda University Ventures and JMTC Capital. | $1.2M |